Exact Mass: 394.0841
Exact Mass Matches: 394.0841
Found 52 metabolites which its exact mass value is equals to given mass value 394.0841,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
9-Hydroxy-4-methoxypsoralen 9-glucoside
4-methoxy-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-7H-furo[3,2-g]chromen-7-one
9-Hydroxy-4-methoxypsoralen 9-glucoside is found in green vegetables. 9-Hydroxy-4-methoxypsoralen 9-glucoside is a constituent of Apium graveolens. Constituent of Apium graveolens. 9-Hydroxy-4-methoxypsoralen 9-glucoside is found in wild celery and green vegetables.
Hexsose + C5H10O3, 1phosphate
[3,4,5-trihydroxy-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentyl] dihydrogen phosphate
Annotation level-3
pyromeconic acid 3-O-beta-D-glucopyranoside 6-(O-4-hydroxybenzoate)|pyromeconic acid 3-O-beta-D-glucopyranoside 6-O-(4-hydroxybenzoate)
pyromeconic acid 3-O-beta-D-glucopyranoside 6-(O-4-hydroxybenzoate)|pyromeconic acid 3-O-beta-D-glucopyranoside 6-O-(4-hydroxybenzoate)
3,4,5-trihydroxy-6-methoxy-2-O-alpha-L-arabinosylbenzophenone
3,4,5-trihydroxy-6-methoxy-2-O-alpha-L-arabinosylbenzophenone
methyl 5-chloro-4-O-demethylbarbatate|metyl 5-chloro-4-O-demethylbarbatate
methyl 5-chloro-4-O-demethylbarbatate|metyl 5-chloro-4-O-demethylbarbatate
9-Hydroxy-4-methoxypsoralen 9-glucoside
5-methoxy-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2H-furo[3,2-g]chromen-2-one
2-(4-DIMETHYLAMINOSTYRYL)-3-METHYLBENZOTHIAZOLIUM PERCHLORATE
2-(4-DIMETHYLAMINOSTYRYL)-3-METHYLBENZOTHIAZOLIUM PERCHLORATE
Gonyautoxin II
Gonyautoxin II
From Gonyaulax and Protogonyaulax subspecies Gonyautoxin II is found in mollusks.
4-di-2-asp
4-(4-Diethylaminostyryl)-1-methylpyridinium iodide
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes
Sivifene
4-[[2-(2,4-dinitrophenyl)hydrazinyl]-(4-hydroxyphenyl)methylidene]cyclohexa-2,5-dien-1-one
C308 - Immunotherapeutic Agent > C2139 - Immunostimulant
2-Chloro-3-phenylsulfonamidopyridine-5-boronic acid pinacol ester
2-Chloro-3-phenylsulfonamidopyridine-5-boronic acid pinacol ester
2-(2,4-dichlorophenoxy)-N-[4-(morpholin-4-ylmethyl)phenyl]acetamide
2-(2,4-dichlorophenoxy)-N-[4-(morpholin-4-ylmethyl)phenyl]acetamide
4-(3,4-dichlorophenyl)-N-(4,6-dimethyl-2-pyridinyl)-1-piperazinecarbothioamide
4-(3,4-dichlorophenyl)-N-(4,6-dimethyl-2-pyridinyl)-1-piperazinecarbothioamide
1-[4-(Benzenesulfonyl)-1-piperazinyl]-2-[(4-fluorophenyl)thio]ethanone
1-[4-(Benzenesulfonyl)-1-piperazinyl]-2-[(4-fluorophenyl)thio]ethanone
N,N-diethyl-2-[(4-fluorophenyl)methylthio]-1,3-benzoxazole-5-sulfonamide
N,N-diethyl-2-[(4-fluorophenyl)methylthio]-1,3-benzoxazole-5-sulfonamide
7-chloro-4-[(2-fluorophenyl)-oxomethyl]-5-phenyl-3,5-dihydro-1H-1,4-benzodiazepin-2-one
7-chloro-4-[(2-fluorophenyl)-oxomethyl]-5-phenyl-3,5-dihydro-1H-1,4-benzodiazepin-2-one
[(3aS,4S,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-oxanyl)methanone
[(3aS,4S,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-oxanyl)methanone
[(3aR,4S,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-oxanyl)methanone
[(3aR,4S,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-oxanyl)methanone
[(3aS,4R,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-oxanyl)methanone
[(3aS,4R,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-oxanyl)methanone
2-(phenylmethylthio)-9-thiophen-2-yl-6,7,8a,9-tetrahydro-5H-[1,2,4]triazolo[5,1-b]quinazolin-8-one
2-(phenylmethylthio)-9-thiophen-2-yl-6,7,8a,9-tetrahydro-5H-[1,2,4]triazolo[5,1-b]quinazolin-8-one
Lorediplon
Lorediplon
Lorediplon is a novel non-benzodiazepine drug acting as a GABAA receptor modulator, differentially active at the alpha1-subunit, associated with promoting sleep. Target: GABA Lorediplon is a drug for the treatment of insomnia, has been successfully completed with a best-in-class efficacy profile in terms of maintaining sleep and sleep quality, Lorediplon targets GABAA. [1] Lorediplon demonstrates a minimum of 10-fold and 6-fold increase in potency (respectively) in the spontaneous motor activation studies. At concentrations of 1.2mg/kg, Lorediplon demonstrates a 57\%increased effect on Slow Wave Sleep (SWS), when compared with a placebo.[2]
{4-[2-(acetyloxy)-5-bromo-4-methylphenyl]-4,5-dimethylcyclopent-1-en-1-yl}methyl acetate
{4-[2-(acetyloxy)-5-bromo-4-methylphenyl]-4,5-dimethylcyclopent-1-en-1-yl}methyl acetate
2-[2-(3,5-dihydroxybenzoyl)-3,5-dihydroxyphenoxy]oxane-3,4,5-triol
2-[2-(3,5-dihydroxybenzoyl)-3,5-dihydroxyphenoxy]oxane-3,4,5-triol
[(4r,5r)-4-[2-(acetyloxy)-5-bromo-4-methylphenyl]-4,5-dimethylcyclopent-1-en-1-yl]methyl acetate
[(4r,5r)-4-[2-(acetyloxy)-5-bromo-4-methylphenyl]-4,5-dimethylcyclopent-1-en-1-yl]methyl acetate
(2s,3r,4s,5s)-2-[2-(3,5-dihydroxybenzoyl)-3,5-dihydroxyphenoxy]oxane-3,4,5-triol
(2s,3r,4s,5s)-2-[2-(3,5-dihydroxybenzoyl)-3,5-dihydroxyphenoxy]oxane-3,4,5-triol
(3s,4s,6r,7r)-9-cyano-3,13-dihydroxy-6-methyl-11,18-dioxo-5-oxa-9-azapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate
(3s,4s,6r,7r)-9-cyano-3,13-dihydroxy-6-methyl-11,18-dioxo-5-oxa-9-azapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(4-oxopyran-3-yl)oxy]oxan-2-yl]methyl 4-hydroxybenzoate
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(4-oxopyran-3-yl)oxy]oxan-2-yl]methyl 4-hydroxybenzoate
(3r,4r,6s,7s)-3,13-dihydroxy-6-methyl-11,18-dioxo-9-(λ⁵-diazynylidene)-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate
(3r,4r,6s,7s)-3,13-dihydroxy-6-methyl-11,18-dioxo-9-(λ⁵-diazynylidene)-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate
[(3as,4r,9r,10as)-4-[(acetyloxy)methyl]-10,10-dihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-9-yl]oxidanesulfonic acid
[(3as,4r,9r,10as)-4-[(acetyloxy)methyl]-10,10-dihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-9-yl]oxidanesulfonic acid
[(3as,4r,9s,10as)-4-[(acetyloxy)methyl]-10,10-dihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-9-yl]oxidanesulfonic acid
[(3as,4r,9s,10as)-4-[(acetyloxy)methyl]-10,10-dihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-9-yl]oxidanesulfonic acid
9-cyano-3,13-dihydroxy-6-methyl-11,18-dioxo-5-oxa-9-azapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate
9-cyano-3,13-dihydroxy-6-methyl-11,18-dioxo-5-oxa-9-azapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate
1-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2-methylanthracene-9,10-dione
1-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2-methylanthracene-9,10-dione
{3,4,5-trihydroxy-6-[(4-oxopyran-3-yl)oxy]oxan-2-yl}methyl 4-hydroxybenzoate
{3,4,5-trihydroxy-6-[(4-oxopyran-3-yl)oxy]oxan-2-yl}methyl 4-hydroxybenzoate
4-methoxy-9-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}furo[3,2-g]chromen-7-one
4-methoxy-9-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}furo[3,2-g]chromen-7-one
(3s,4s,6r,7r)-3,13-dihydroxy-6-methyl-11,18-dioxo-9-(λ⁵-diazynylidene)-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate
(3s,4s,6r,7r)-3,13-dihydroxy-6-methyl-11,18-dioxo-9-(λ⁵-diazynylidene)-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate
(3s,4s,6r,7r)-7-(acetyloxy)-9-(diazyn-1-ium-1-yl)-3,13-dihydroxy-6-methyl-11-oxo-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(18),2(8),9,12,14,16-hexaen-18-olate
(3s,4s,6r,7r)-7-(acetyloxy)-9-(diazyn-1-ium-1-yl)-3,13-dihydroxy-6-methyl-11-oxo-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(18),2(8),9,12,14,16-hexaen-18-olate
(2s,3r,4s,5r)-2-[2-(3,5-dihydroxybenzoyl)-3,5-dihydroxyphenoxy]oxane-3,4,5-triol
(2s,3r,4s,5r)-2-[2-(3,5-dihydroxybenzoyl)-3,5-dihydroxyphenoxy]oxane-3,4,5-triol
3,13-dihydroxy-6-methyl-11,18-dioxo-9-(λ⁵-diazynylidene)-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate
3,13-dihydroxy-6-methyl-11,18-dioxo-9-(λ⁵-diazynylidene)-5-oxapentacyclo[8.8.0.0²,⁸.0⁴,⁶.0¹²,¹⁷]octadeca-1(10),2(8),12,14,16-pentaen-7-yl acetate
(2s,3s,4s,5r,6s)-6-[(6-carboxy-4-hydroxy-2-methylnaphthalen-1-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
(2s,3s,4s,5r,6s)-6-[(6-carboxy-4-hydroxy-2-methylnaphthalen-1-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
